Compile Data Set for Download or QSAR
maximum 50k data
Found 172 with Last Name = 'pearson' and Initial = 'd'
TargetSomatostatin receptor type 1/2/3/4/5(RAT)
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476140(CHEMBL373632)
Affinity DataIC50:  0.100nMAssay Description:Displacement of [125I]SRIF-14 from SSTR of rat AR42J cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(Homo sapiens (Human))
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476134(CHEMBL437296)
Affinity DataIC50:  0.200nMAssay Description:Displacement of [125I-Tyr-11]-SRIF from SSTR of human NCI-H69 cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(Homo sapiens (Human))
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476138(CHEMBL376485)
Affinity DataIC50:  0.350nMAssay Description:Displacement of [125I-Tyr-11]-SRIF from SSTR of human NCI-H69 cell membranesMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(RAT)
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476137(CHEMBL222751)
Affinity DataIC50:  0.400nMAssay Description:Displacement of [125I]SRIF-14 from SSTR of rat AR42J cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(Homo sapiens (Human))
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476142(CHEMBL376484)
Affinity DataIC50:  0.5nMAssay Description:Displacement of [125I-Tyr-11]-SRIF from SSTR of human NCI-H69 cell membranesMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(Homo sapiens (Human))
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476141(CHEMBL426548)
Affinity DataIC50:  0.640nMAssay Description:Displacement of [125I-Tyr-11]-SRIF from SSTR of human NCI-H69 cell membranesMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(RAT)
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476135(CHEMBL374316)
Affinity DataIC50:  0.700nMAssay Description:Displacement of [125I]SRIF-14 from SSTR of rat AR42J cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(Homo sapiens (Human))
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50192018(CHEMBL3350037)
Affinity DataIC50:  1.10nMAssay Description:Displacement of [125I-Tyr-11]-SRIF from SSTR of human NCI-H69 cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(RAT)
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476143(CHEMBL376001)
Affinity DataIC50:  1.5nMAssay Description:Displacement of [125I]SRIF-14 from SSTR of rat AR42J cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(Homo sapiens (Human))
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476136(CHEMBL222699)
Affinity DataIC50:  1.60nMAssay Description:Displacement of [125I-Tyr-11]-SRIF from SSTR of human NCI-H69 cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1/2/3/4/5(Homo sapiens (Human))
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476139(CHEMBL268060)
Affinity DataIC50:  1.60nMAssay Description:Displacement of [125I-Tyr-11]-SRIF from SSTR of human NCI-H69 cell membranesMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406678(US10336752, Compound 16 | US11040967, Compound 16)
Affinity DataIC50:  17.7nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406678(US10336752, Compound 16 | US11040967, Compound 16)
Affinity DataIC50:  17.7nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM291729(N-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)-8-...)
Affinity DataIC50:  19nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using bufuralol as substrate incubated for 10 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetSomatostatin receptor type 1/2/3/4/5(RAT)
Diatide Research Laboaratories

Curated by ChEMBL
LigandPNGBDBM50476144(CHEMBL434761)
Affinity DataIC50:  24nMAssay Description:Displacement of [125I]SRIF-14 from SSTR of rat AR42J cell membranesMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332998(US10196390, Compound I-287 | US10336752, Compound ...)
Affinity DataIC50:  24.2nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332998(US10196390, Compound I-287 | US10336752, Compound ...)
Affinity DataIC50:  24.2nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332882(US10196390, Compound I-171 | US10336752, Compound ...)
Affinity DataIC50:  33nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332882(US10196390, Compound I-171 | US10336752, Compound ...)
Affinity DataIC50:  33nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  56.9nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  56.9nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  72.6nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  72.6nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406676(US10336752, Compound 15 | US11040967, Compound 15)
Affinity DataIC50:  74.1nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406676(US10336752, Compound 15 | US11040967, Compound 15)
Affinity DataIC50:  74.1nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  78.5nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  78.5nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  85.3nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  85.3nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406679(US10336752, Compound 17 | US10968236, Compound I-6...)
Affinity DataIC50:  88.6nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406679(US10336752, Compound 17 | US10968236, Compound I-6...)
Affinity DataIC50:  88.6nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332968(US10196390, Compound I-257 | US10336752, Compound ...)
Affinity DataIC50:  90nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332968(US10196390, Compound I-257 | US10336752, Compound ...)
Affinity DataIC50:  90nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  93.2nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM406663(US10336752, Compound 1 | US10336752, Compound 2 | ...)
Affinity DataIC50:  93.2nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM291701(N-((2,3-dihydrobenzofuran-4-yl)methyl)-8-(pyridin-...)
Affinity DataIC50:  100nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using bufuralol as substrate incubated for 10 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332970(US10196390, Compound I-259 | US10336752, Compound ...)
Affinity DataIC50:  119nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332970(US10196390, Compound I-259 | US10336752, Compound ...)
Affinity DataIC50:  119nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332942(US10196390, Compound I-231 | US10336752, Compound ...)
Affinity DataIC50:  134nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332942(US10196390, Compound I-231 | US10336752, Compound ...)
Affinity DataIC50:  134nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332986(US10196390, Compound I-275 | US10336752, Compound ...)
Affinity DataIC50:  136nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332986(US10196390, Compound I-275 | US10336752, Compound ...)
Affinity DataIC50:  136nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM291702(N-((2,3-dihydrobenzofuran-4-yl)methyl)-8-(pyridin-...)
Affinity DataIC50:  160nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate incubated for 10 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM291702(N-((2,3-dihydrobenzofuran-4-yl)methyl)-8-(pyridin-...)
Affinity DataIC50:  200nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using bufuralol as substrate incubated for 10 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332916(US10196390, Compound I-205 | US10336752, Compound ...)
Affinity DataIC50:  390nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1× kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Nimbus Lakshmi

US Patent
LigandPNGBDBM332916(US10196390, Compound I-205 | US10336752, Compound ...)
Affinity DataIC50:  390nMAssay Description:Compounds were serially diluted in DMSO then further diluted in 1x kinase buffer: 5 uL of buffer diluted compound was added into wells first, then 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50604673(CHEMBL5197950)
Affinity DataIC50:  400nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using bufuralol as substrate incubated for 10 mins in presence of NADPH by LC-MS/MS analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetVitamin D3 receptor(Homo sapiens (Human))
University Of Wisconsin-Milwaukee

Curated by ChEMBL
LigandPNGBDBM50389887(CHEMBL2070841)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of VDR-LBD expressed in human HEK293T cells co-expressing GAL4-DBD assessed as inhibition of 1,25-(OH)2D3-induced transcription after 24 h...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM291687(N-((5-Fluoro-2,3-dihydrobenzofuran-4-yl)methyl)-8-...)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of vesicular monoamine transporter 2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetVitamin D3 receptor(Homo sapiens (Human))
University Of Wisconsin-Milwaukee

Curated by ChEMBL
LigandPNGBDBM60445((6-piperidinosulfonyl-1,3-benzothiazol-2-yl)amine ...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of LG190178-induced VDR-LBD interaction to Alexa Fluor 647-labeled SRC2-3 after 3 hrs by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 172 total ) | Next | Last >>
Jump to: